Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a report published on Tuesday morning. The firm issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of Retractable Technologies stock opened at $0.59 on Tuesday. The firm has a market cap of $17.60 million, a P/E ratio of -1.06 and a beta of 2.06. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 12 month low of $0.56 and a 12 month high of $1.34. The stock’s fifty day moving average price is $0.76 and its 200-day moving average price is $0.96.

Insider Buying and Selling at Retractable Technologies

In related news, CEO Thomas J. Shaw bought 71,422 shares of the business’s stock in a transaction on Friday, September 20th. The shares were bought at an average price of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the purchase, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This trade represents a 0.49 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have purchased 179,649 shares of company stock worth $143,163 over the last quarter. Insiders own 54.60% of the company’s stock.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent filing with the Securities & Exchange Commission. 7.58% of the stock is currently owned by institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.